Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Interleukin-32 Induce Production of IL-6 in Multiple Myeloma Bone Marrow Stromal Cells

Xuanru Lin, M.MD, Xing Guo, M.MD, Jing Chen, M.MD, Qingxiao Chen, M.MD, Enfan Zhang, M.MD, Yi Li, PhD, Li Yang, PhD, Jingsong He, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 3253.

https://doi.org/10.1182/blood.V128.22.3253.3253

Published: 2016

Journal Articles

TET2 Downregulation Promotes AML Cell Proliferation Via Pim-1 Expression

Qingxiao Chen, M.MD, Jingsong He, Xing Guo, M.MD, Jing Chen, M.MD, Xuanru Lin, M.MD, Xi Huang, M.MD, Haimeng Yan, Li Yang, PhD, Yi Li, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 5085.

https://doi.org/10.1182/blood.V128.22.5085.5085

Published: 2016

Journal Articles

Interactions Between BAFF and BAFF Receptors Are Involved in Macrophage-Induced Bortezomib Resistance in Myeloma

Jing Chen, M.MD, Donghua He, PhD, Xing Guo, M.MD, Qingxiao Chen, M.MD, Xuanru Lin, M.MD, Jingsong He, Xi Huang, M.MD, Haimeng Yan, Yi Li, PhD, Li Yang, PhD, Yang Yang, PhD, Enfan Zhang, M.MD, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 4429.

https://doi.org/10.1182/blood.V128.22.4429.4429

Published: 2016

Journal Articles

Interference of HMGB1 Lead to Increased Vulnerability of MM Cells to Dexamethasone and Doxorubicin

Xing Guo, M.MD, Donghua He, PhD, Jing Chen, M.MD, Xuanru Lin, M.MD, Qingxiao Chen, M.MD, Haimeng Yan, Xi Huang, M.MD, Yi Li, PhD, Li Yang, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, Wenjun Wu, MD, Jingsong He, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 2086.

https://doi.org/10.1182/blood.V128.22.2086.2086

Published: 2016

Journal Articles

NEDD4-1 Modulates the Resistance of Multiple Myeloma to Bortezomib

Xi Huang, M.MD, Enfan Zhang, M.MD, Xing Guo, M.MD, Jing Chen, M.MD, Xuanru Lin, M.MD, Qingxiao Chen, M.MD, Haimeng Yan, Li Yang, PhD, Yi Li, PhD, Jingsong He, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 2068.

https://doi.org/10.1182/blood.V128.22.2068.2068

Published: 2016

Journal Articles

TET2 Downregulation Leads to AML Cells Sensitive to Decitabine

Qingxiao Chen, M.MD, Jingsong He, PhD, Xing Guo, M.MD, Jing Chen, M.MD, Li Yang, PhD, Xuanru Lin, M.MD, Yi Li, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, Wenjun Wu, MD, Donghua He, PhD, He Huang, MD PhD, Shizhou Liu, MD PhD, Zhen Cai, MD PhD

Blood (2015) 126 (23): 3643.

https://doi.org/10.1182/blood.V126.23.3643.3643

Published: 2015

Journal Articles

Quercetin Displays Anti-Myeloma Activity and Synergistic Effect with Dexamethasone in Vitro and In Vivo Xenograft Models

Xing Guo, M.MD, Donghua He, PhD, Li Yang, PhD, Yi Li, PhD, Qingxiao Chen, M.MD, Jing Chen, M.MD, Enfan Zhang, M.MD, Xuanru Lin, M.MD, Jingsong He, PhD, Yang Yang, PhD, Xiaoyan Han, MD, Gaofeng Zheng, MD, Wenjun Wu, MD, Yi Zhao, PhD, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2015) 126 (23): 5339.

https://doi.org/10.1182/blood.V126.23.5339.5339

Published: 2015

Journal Articles

Bortezomib-Resistance Is Characterized By Upregulation of E3 Ligase Pirh2 Which Protects Bortezomib Induced Apoptosis in Multiple Myeloma Cells

Li Yang, M.MD, Jingsong He, Yi Li, M.MD, Xing Guo, M.MD, Jing Chen, M.MD, Qingxiao Chen, M.MD, Xuanru Lin, M.MD, Donghua He, PhD, Yang Yang, PhD, Enfan Zhang, M.MD, Xiaoyan Han, M.MD, Wenjun Wu, M.MD, Yi Zhao, PhD, Gaofeng Zheng, M.MD, He Huang, MDPhD, Zhen Cai, MDPhD

Blood (2014) 124 (21): 3391.

https://doi.org/10.1182/blood.V124.21.3391.3391

Published: 2014

Journal Articles

The Role BAFF and BAFF Receptors in Macrophage Induced Drug Resistance of Multiple Myeloma

Jing Chen, M.MD, Donghua He, PhD, Xing Guo, M.MD, Li Yang, M.MD, Yi Li, M.MD, Qingxiao Chen, M.MD, Jingsong He, Yang Yang, PhD, Enfan Zhang, M.MD, WenJun Wu, Xiaoyan Han, M.MD, Gaofeng Zheng, M.MD, Yi Zhao, PhD, He Huang, MDPhD, Zhen Cai, MDPhD

Blood (2014) 124 (21): 5701.

https://doi.org/10.1182/blood.V124.21.5701.5701

Published: 2014

Journal Articles

Targeting HMGB1 Increased the Sensitivity of MM Cells to Chemotherapy

Xing Guo, M.MD, Donghua He, PhD, Jing Chen, M.MD, Li Yang, M.MD, Yi Li, M.MD, Qingxiao Chen, M.MD, Jingsong He, Yang Yang, PhD, Enfan Zhang, M.MD, Wenjun Wu, M.MD, Xiaoyan Han, M.MD, Gaofeng Zheng, M.MD, Yi Zhao, PhD, He Huang, MDPhD, Zhen Cai, MDPhD

Blood (2014) 124 (21): 5703.

https://doi.org/10.1182/blood.V124.21.5703.5703

Published: 2014

NARROW

Interleukin-32 Induce Production of IL-6 in Multiple Myeloma Bone Marrow Stromal Cells

TET2 Downregulation Promotes AML Cell Proliferation Via Pim-1 Expression

Interactions Between BAFF and BAFF Receptors Are Involved in Macrophage-Induced Bortezomib Resistance in Myeloma

Interference of HMGB1 Lead to Increased Vulnerability of MM Cells to Dexamethasone and Doxorubicin

NEDD4-1 Modulates the Resistance of Multiple Myeloma to Bortezomib

TET2 Downregulation Leads to AML Cells Sensitive to Decitabine

Quercetin Displays Anti-Myeloma Activity and Synergistic Effect with Dexamethasone in Vitro and In Vivo Xenograft Models

Bortezomib-Resistance Is Characterized By Upregulation of E3 Ligase Pirh2 Which Protects Bortezomib Induced Apoptosis in Multiple Myeloma Cells

The Role BAFF and BAFF Receptors in Macrophage Induced Drug Resistance of Multiple Myeloma

Targeting HMGB1 Increased the Sensitivity of MM Cells to Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only